Trial Profile
Risk of cancer in patients with osteoporosis treated with osteoporotic therapy (alendronic acid, ibandronic acid,zolendronic acid,raloxifen,teriparatide,denosumab)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jul 2017
Price :
$35
*
At a glance
- Drugs Alendronic acid (Primary) ; Denosumab (Primary) ; Ibandronic acid (Primary) ; Raloxifene (Primary) ; Teriparatide (Primary) ; Zoledronic acid (Primary)
- Indications Osteoporosis
- Focus Adverse reactions
- 03 Jul 2017 New trial record
- 17 Jun 2017 Results presented at the 18th Annual Congress of the European League Against Rheumatism